These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15602800)

  • 1. Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspects.
    Warot D; Berlin I; Aymard G; Ankri A; Fabry C; Besse B; Lechat P; Diquet B
    Fundam Clin Pharmacol; 2000; 14(3):231-6. PubMed ID: 15602800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy.
    Verstuyft C; Delavenne X; Rousseau A; Robert A; Tod M; Diquet B; Lebot M; Jaillon P; Becquemont L
    Clin Pharmacokinet; 2012 Jan; 51(1):41-53. PubMed ID: 22149257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians.
    Comets E; Diquet B; Legrain S; Huisse MG; Godon A; Bruhat C; Chauveheid MP; Delpierre S; Duval X; Berrut G; Verstuyft C; Aumont MC; Mentré F
    Clin Pharmacol Ther; 2012 May; 91(5):777-86. PubMed ID: 22472992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and platelet antiaggregating effects of beraprost, an oral stable prostacyclin analogue, in healthy volunteers.
    Demolis JL; Robert A; Mouren M; Funck-Brentano C; Jaillon P
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):711-6. PubMed ID: 7506323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients.
    Mentré F; Pousset F; Comets E; Plaud B; Diquet B; Montalescot G; Ankri A; Mallet A; Lechat P
    Clin Pharmacol Ther; 1998 Jan; 63(1):64-78. PubMed ID: 9465843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling INR data to predict maintenance fluindione dosage.
    Comets E; Mentré F; Pousset F; Diquet B; Montalescot G; Ankri A; Mallet A; Lechat P
    Ther Drug Monit; 1998 Dec; 20(6):631-9. PubMed ID: 9853979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.
    Nony P; Ffrench P; Girard P; Delair S; Azoulay S; Girre JP; Dechavanne M; Boissel JP
    Can J Physiol Pharmacol; 1996 Aug; 74(8):887-93. PubMed ID: 8960377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.
    Sellam J; Costedoat-Chalumeau N; Amoura Z; Aymard G; Choquet S; Trad S; Vignes BL; Hulot JS; Berenbaum F; Lechat P; Cacoub P; Ankri A; Mariette X; Leblond V; Piette JC
    Joint Bone Spine; 2007 Oct; 74(5):446-52. PubMed ID: 17692552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.
    Costedoat-Chalumeau N; Amoura Z; Aymard G; Sevin O; Wechsler B; Cacoub P; Du LT; Diquet B; Ankri A; Piette JC
    Ann Intern Med; 2000 Apr; 132(8):631-5. PubMed ID: 10766681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin.
    Bossavy JP; Sakariassen KS; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2269-75. PubMed ID: 10479672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of regimen fluindione needed for anticoagulation in the elderly].
    Lechowski L; Teillet L; Harboun M; Tortrat D; Forette B
    Rev Med Interne; 2002 Dec; 23(12):1022-6. PubMed ID: 12504240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of fluindione maintenance dosage hampered by large intraindividual variability.
    Comets E; Pousset F; Mentré F; Diquet B; Ankri A; Mallet A; Lechat P
    Ther Drug Monit; 2000 Dec; 22(6):668-75. PubMed ID: 11128234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting daily maintenance dose of fluindione, an oral anticoagulant drug.
    Cazaux V; Gauthier B; Elias A; Lefebvre D; Tredez J; Nguyen F; Cambus JP; Boneu B; Boccalon H
    Thromb Haemost; 1996 May; 75(5):731-3. PubMed ID: 8725714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of restenosis by beraprost sodium (a prostaglandin I2 analogue) in the atherosclerotic rabbit artery after angioplasty.
    Isogaya M; Yamada N; Koike H; Ueno Y; Kumagai H; Ochi Y; Okazaki S; Nishio S
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):947-52. PubMed ID: 7564340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a mobile electronic assistant to aid in fluindione prescription: the INRPlus cluster randomized trial.
    Imbert P; Pernod G; Jacquet JP; Bailly C; Laporte S; Lievre M;
    Thromb Res; 2014 May; 133(5):756-61. PubMed ID: 24582071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers.
    Huang HL; Vaidyanathan S; Yeh CM; Bizot MN; Dieterich HA; Dole WP; Howard D
    Curr Med Res Opin; 2008 Sep; 24(9):2449-56. PubMed ID: 18662494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group.
    Leroyer C; Bressollette L; Oger E; Mansourati J; Chèze-Le Rest C; Nonent M; Buchmuller A; Tardy B; Decousus H; Parent F; Simonneau G; Juste K; Ill P; Abgrall JF; Clavier J; Mottier D
    Haemostasis; 1998; 28(2):70-7. PubMed ID: 10087431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.
    Jindal D; Tandon M; Sharma S; Pillai KK
    Eur J Clin Pharmacol; 2005 Oct; 61(9):621-5. PubMed ID: 16133549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.